Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Myocardial Ischemia

5,8,11,14-eicosatetraynoic acid has been researched along with Myocardial Ischemia in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, E1
Glasgow, W1
Fralix, T1
Steenbergen, C1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and Myocardial Ischemia

ArticleYear
Role of lipoxygenase metabolites in ischemic preconditioning.
    Circulation research, 1995, Volume: 76, Issue:3

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Ac

1995